InvestorsHub Logo
Followers 0
Posts 134
Boards Moderated 0
Alias Born 12/12/2014

Re: None

Thursday, 09/27/2018 1:07:45 PM

Thursday, September 27, 2018 1:07:45 PM

Post# of 9943
From Inmed’s twitter feed on epidiolex reclassification:
InMed Pharmaceutical
@inmedpharma
Exciting news in the #cannabinoid space! GW Pharma’s EPIDIOLEX® oral solution has been transferred to Schedule V, the lowest restriction classification, by the U.S. DEA, paving the path for InMed’s novel cannabinoid-based candidates.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News